FOXO3 and gastric cancer: Collectively, our present study revealed a novel mechanism modulated by IFITM3-associated HGF/MET/AKT signaling complexes that suppressed FOXO3, consequently leading to c-MYC upregulation to promote cell proliferation, metastasis, stemness and chemoresistance in GC (Fig. 8).